PrimeBioMed LLC provides cancer and infections diseases diagnostic reagents for different instruments and diagnostics plattforms. We also provide services to our partners to accelerate IVD and Research products development and commercialization. PrimeBioMed LLC is participant of Skolkovo Foundation (www.sk.ru) and Russian Venture Fund (www.rvc.ru).
Our team provides a broad range of high quality research & development services. Our advantages: highly professional team; access to large collections of clinical samples and patient cohorts with cardiovascular diseases, cancer or metabolic diseases; well defined primary cell-based experimental systems; certified animal facility. All projects run under controlled conditions, certified in accordance with ISO13485 standard.
Our primary fields of expertize are: • Development of expression systems for recombinant proteins (bacterial, mammalian, yeast). • Development of cell-based systems for drug testing. • Custom research of a drug in various cell-based systems, including monocytes/macrophages, endothelial cell, keratinocytes, mesenchymal stem cells. • Screening studies of new diagnostic antibodies. • Development of multiplex assays for the analysis of soluble analytes • Development of antibody-based detection systems for various applications. • Development of ELISA.